Adjuvant Immunotherapy Trial may be preferable to Adjuvant therapy in Kidney Cancer - 100459

Spotlight
Video

Adjuvant Immunotherapy Trial may be preferable to Adjuvant therapy in Kidney Cancer

moasc has 333 videos Subscribe Here

Loading........
Description: Sumanta (Monty) Kumar Pal, M.D. Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research Co-director, Kidney Cancer Program, Medical Oncologist, explains how the Adjuvant immunotherapy trial may be preferable to Adjuvant therapy in Kidney Cancer in the 2018 Oncology Summit in Huntington Beach, CA
Shared By : moasc
Posted on : 03/06/18
Added : 10 months ago
Category : Kidney Cancer



Recommended

Nothing found.